Supply of Drugs and Medicines for Cancer Patients under Pakistan Bait Ul Mal (I.F.A) Programme FY 2026-27

The Atomic Energy Cancer Hospital (NIMRA) Jamshoro invites bids from well reputed pharmaceutical companies, approved distributors, firms, and suppliers across Pakistan for the supply of drugs and medicines for cancer patients under the Pakistan Bait Ul Mal (I.F.A) Programme for the financial year 2026-27. This procurement is conducted under Sindh Public Procurement Rules 2010 (amended 2019) using a Single Stage Two Envelope procedure via the SPPRA EPADS portal. Items being procured include a comprehensive list of targeted therapy drugs, chemotherapy medicines, and general medicines as detailed in the Bill of Quantities. Some key medicines include Inj: Adalinumab 40mg, Inj: Bevacizumab 100mg and 400mg, Tab: Axitinib 5mg, Inj: Cisplatin 50mg, Tab: Capecitabine 500mg, Inj: Doxorubicin 10mg and 50mg, Inj: Paclitaxel 30mg to 300mg, Tab: Tamoxifen 10mg and 20mg, Inj: Erythropoietin 4000IU, Inj: Meropenem 1g, and many others covering a wide range of oncology and supportive care medicines. The technical scope requires compliance with the specifications and standards outlined in the bidding documents. Bidders must be registered with DRAP, FBR, and Sales Tax Department, and have at least three years of relevant supply experience in reputable hospitals. The selection criteria are quality and cost-based, with mandatory submission of tender fees, bid security, and all required documentation including proof of registration, tax compliance, and past performance certificates. The deadline for bid submission is **09-11-2026 at 11:00 AM**, with bid opening scheduled for the same day at 11:30 AM in the Auditorium Hall of AECH-NIMRA Jamshoro. Bids must be submitted electronically via the SPPRA EPADS portal. Tender documents can be downloaded starting from the date of publication. Tender fees of Rs. 5000/- are payable via demand draft or pay order in favor of General Secretary CPWS NIMRA. A practical tip for bidders is to ensure all mandatory documents are complete and properly signed, as incomplete bids will be rejected. Also, bidders should carefully review the detailed Bill of Quantities and technical specifications to ensure full compliance and competitive pricing. Early submission via EPADS is recommended to avoid last-minute technical issues. For further information and clarifications, bidders may contact the Welfare Incharge at Atomic Energy Cancer Hospital (NIMRA), Jamshoro, via phone +9222-9213388 or email nimrajam@yahoo.com.